Phase 2 COPD Trial, Recruiting NCT07037836 Sponsor: Bastiaan Driehuys Condition: COPD
Back to Copd

Phase 2 COPD Trial, Recruiting

NCT07037836
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 40 years old or older and are being seen as an outpatient (not currently admitted to a hospital)
  • You have chronic bronchitis, meaning you have had a mucus-producing cough for more than 3 months within a 2-year period
  • You are a current or former smoker with at least a 20 pack-year smoking history (for example, smoking one pack a day for 20 years, or two packs a day for 10 years)
  • You have been diagnosed with COPD, confirmed by breathing tests showing specific results related to how much air you can breathe in and out (confirm with trial site for exact test values)
  • You have been on stable COPD medications — such as inhalers or other prescribed COPD treatments — with no changes in the past 3 months
  • You use supplemental oxygen at rest or during activity, at a flow of 4 liters per minute or less
  • You are willing and able to give your consent to participate and to follow the study schedule and requirements
  • If you are a woman who could become pregnant, you must have a negative blood pregnancy test before joining

Who may not be able to join:

  • You have had an upper respiratory infection (such as a chest cold) within the past 6 weeks (you may be able to reapply after this period)
  • You have previously had surgery to remove part of a lung or surgery on the lining around the lung
  • You have a history of a collapsed lung (pneumothorax)
  • Scans have shown signs of certain other lung conditions, such as scarring of the lungs, lung disease caused by your job or environment, or a long-term lung infection
  • You have a history of asthma
  • You have been significantly exposed to harmful substances at work or in your environment that are known to cause lung disease
  • You have a positive pregnancy test (for women who could become pregnant)
  • You have another serious ongoing health condition that the study doctor believes would make it difficult for you to participate safely
  • You have any reason you cannot safely have an MRI scan (based on a screening questionnaire)
  • You are currently pregnant or breastfeeding
  • You have had a bacterial or viral respiratory illness within 6 weeks before the MRI scan
  • You have a known heart rhythm problem (cardiac arrhythmia)
  • You are unable to fit into the special vest used during the MRI scan (confirm with trial site)
  • You are unable to hold your breath for 10 seconds
  • You would have difficulty following instructions during the MRI scan

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: 919-684-3069

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Bastiaan Driehuys
Registry
ClinicalTrials.gov
Start date
29 September 2025
Est. completion
1 July 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Ventilation Defect Percentage (VDP) on HP129XeMRI; Membrane Defect Percentage on HP129XeMRI; Low Membrane Region Percentage on HP129XeMRI; RBC Transfer Defect Percentage on HP129XeMRI; Low RBC Transfer Region Percentage on HP129XeMRI; RBC Oscillation Amplitude Normalized for RBC Transfer Defect; RBC Chemical Shift on HP129XeMRI Spectroscopy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov